ZIOPHARM ONCOLOGY INC Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ZIOPHARM ONCOLOGY INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ZIOPHARM ONCOLOGY INC for January 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Option Exercise | J | 0.00 | 1,196 | 0 | 120,840 | |
| Jan 03 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | WEISER MICHAEL | Director | Payment of Exercise | F | 4.14 | 6,021 | 24,927 | 224,282 | 230.3 K to 224.3 K (-2.61 %) |
| Jan 03 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | WEISER MICHAEL | Director | Grant | A | 0.00 | 17,258 | 0 | 230,303 | 213 K to 230.3 K (+8.10 %) |
| Jan 03 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | Tarriff Scott | Director | Option Exercise | A | 4.14 | 25,000 | 103,500 | 25,000 | |
| Jan 03 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | Fowler Wyche | Director | Payment of Exercise | F | 4.14 | 6,882 | 28,491 | 156,446 | 163.3 K to 156.4 K (-4.21 %) |
| Jan 03 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | Fowler Wyche | Director | Grant | A | 0.00 | 17,258 | 0 | 163,328 | 146.1 K to 163.3 K (+11.81 %) |
| Jan 03 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | Cooper Laurence James Neil | Chief Executive Off ... | Payment of Exercise | F | 4.14 | 16,157 | 66,890 | 1,389,396 | 1.4 M to 1.4 M (-1.15 %) |
| Jan 03 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | Cooper Laurence James Neil | Chief Executive Off ... | Payment of Exercise | F | 4.14 | 26,178 | 108,377 | 1,405,553 | 1.4 M to 1.4 M (-1.83 %) |
| Jan 03 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | Cooper Laurence James Neil | Chief Executive Off ... | Grant | A | 0.00 | 348,000 | 0 | 1,431,731 | 1.1 M to 1.4 M (+32.11 %) |
| Jan 03 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | BELBEL CAESAR J | COO, CLO, and Secre ... | Payment of Exercise | F | 4.14 | 21,667 | 89,701 | 207,434 | 229.1 K to 207.4 K (-9.46 %) |
| Jan 03 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | BELBEL CAESAR J | COO, CLO, and Secre ... | Payment of Exercise | F | 4.14 | 31,450 | 130,203 | 229,101 | 260.6 K to 229.1 K (-12.07 %) |
| Jan 03 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | BELBEL CAESAR J | COO, CLO, and Secre ... | Grant | A | 0.00 | 87,000 | 0 | 260,551 | 173.6 K to 260.6 K (+50.13 %) |